Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1987 Mar;90(3):593–599. doi: 10.1111/j.1476-5381.1987.tb11210.x

Cellular electrophysiological effects of D- and DL-sotalol in guinea-pig sinoatrial node, atrium and ventricle and human atrium: differential tissue sensitivity.

T J Campbell
PMCID: PMC1917192  PMID: 3567463

Abstract

The effects of racemic DL-sotalol and D-sotalol on guinea-pig sino-atrial node, atrium and ventricle and on human atrium were studied using standard microelectrode techniques. Both compounds increased spontaneous sinus node cycle length largely by prolonging the repolarization phase of the action potentials. This effect was attributed to blockade of outward potassium current. Ventricular action potential duration was similarly prolonged by DL-sotalol at concentrations of 5-50 microM. DL-Sotalol 1-50 microM had no effect on guinea-pig atrial action potential duration and D-sotalol produced minor prolongation only at the highest concentration (50 microM). Human atrial action potentials were, however, significantly prolonged by both DL- and D-sotalol 10 microM. This indicates differential sensitivities to sotalol for human and guinea-pig atrium and explains the ability of sotalol to prolong atrial monophasic action potential duration in clinical studies.

Full text

PDF
599

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett D. H. Acute prolongation of myocardial refractoriness by sotalol. Br Heart J. 1982 Jun;47(6):521–526. doi: 10.1136/hrt.47.6.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Campbell T. J., Gavaghan T. P., Morgan J. J. Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial. Br Heart J. 1985 Jul;54(1):86–90. doi: 10.1136/hrt.54.1.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carmeliet E. Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. J Pharmacol Exp Ther. 1985 Mar;232(3):817–825. [PubMed] [Google Scholar]
  4. Echt D. S., Berte L. E., Clusin W. T., Samuelsson R. G., Harrison D. C., Mason J. W. Prolongation of the human cardiac monophasic action potential by sotalol. Am J Cardiol. 1982 Nov;50(5):1082–1086. doi: 10.1016/0002-9149(82)90421-0. [DOI] [PubMed] [Google Scholar]
  5. Edvardsson N., Hirsch I., Emanuelsson H., Pontén J., Olsson S. B. Sotalol-induced delayed ventricular repolarization in man. Eur Heart J. 1980 Oct;1(5):335–343. doi: 10.1093/eurheartj/1.5.335. [DOI] [PubMed] [Google Scholar]
  6. Elonen E., Neuvonen P. J., Tarssanen L., Kala R. Sotalol intoxication with prolonged Q-T interval and severe tachyarrhythmias. Br Med J. 1979 May 5;1(6172):1184–1184. doi: 10.1136/bmj.1.6172.1184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hayward R. P., Taggart P. Effect of sotalol on human atrial action potential duration and refractoriness: cycle length dependency of class III activity. Cardiovasc Res. 1986 Feb;20(2):100–107. doi: 10.1093/cvr/20.2.100. [DOI] [PubMed] [Google Scholar]
  8. Kato R., Ikeda N., Yabek S. M., Kannan R., Singh B. N. Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics. J Am Coll Cardiol. 1986 Jan;7(1):116–125. doi: 10.1016/s0735-1097(86)80268-6. [DOI] [PubMed] [Google Scholar]
  9. Lish P. M., Weikel J. H., Dungan K. W. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists. J Pharmacol Exp Ther. 1965 Aug;149(2):161–173. [PubMed] [Google Scholar]
  10. Lynch J. J., Wilber D. J., Montgomery D. G., Hsieh T. M., Patterson E., Lucchesi B. R. Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol. J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1132–1141. [PubMed] [Google Scholar]
  11. Nademanee K., Feld G., Hendrickson J., Singh P. N., Singh B. N. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias. Circulation. 1985 Sep;72(3):555–564. doi: 10.1161/01.cir.72.3.555. [DOI] [PubMed] [Google Scholar]
  12. Nathan A. W., Hellestrand K. J., Bexton R. S., Ward D. E., Spurrell R. A., Camm A. J. Electrophysiological effects of sotalol--just another beta blocker? Br Heart J. 1982 Jun;47(6):515–520. doi: 10.1136/hrt.47.6.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Neuvonen P. J., Elonen E., Tanskanen A., Tuomilehto J. Sotalol and prolonged Q-Tc interval. Lancet. 1981 Aug 22;2(8243):426–426. doi: 10.1016/s0140-6736(81)90876-x. [DOI] [PubMed] [Google Scholar]
  14. Noble D., Noble S. J. A model of sino-atrial node electrical activity based on a modification of the DiFrancesco-Noble (1984) equations. Proc R Soc Lond B Biol Sci. 1984 Sep 22;222(1228):295–304. doi: 10.1098/rspb.1984.0065. [DOI] [PubMed] [Google Scholar]
  15. Senges J., Lengfelder W., Jauernig R., Czygan E., Brachmann J., Rizos I., Cobbe S., Kübler W. Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia. Circulation. 1984 Mar;69(3):577–584. doi: 10.1161/01.cir.69.3.577. [DOI] [PubMed] [Google Scholar]
  16. Singh B. N., Vaughan Williams E. M. A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol. 1970 Aug;39(4):675–687. doi: 10.1111/j.1476-5381.1970.tb09893.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Somani P., Watson D. L. Antiarrhythmic activity of the dextro- and levorotatory isomers of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999). J Pharmacol Exp Ther. 1968 Dec;164(2):317–325. [PubMed] [Google Scholar]
  18. Strauss H. C., Bigger J. T., Jr, Hoffman B. F. Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ Res. 1970 Jun;26(6):661–678. doi: 10.1161/01.res.26.6.661. [DOI] [PubMed] [Google Scholar]
  19. Touboul P., Atallah G., Kirkorian G., Lamaud M., Moleur P. Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties. Am Heart J. 1984 May;107(5 Pt 1):888–895. doi: 10.1016/0002-8703(84)90823-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES